Cipher PharmaceuticalsCipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage productsProductsCipher develops and acquires best-in-class products for unmet medical needsPipelinePhase III studies are underway for two Cipher product candidatesInvestorsFinancial ReportsInvestor PresentationCorporate GovernanceEvents & WebcastsLatest News Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results March 14, 2024Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call March 8, 2024Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading January 29, 2024Press ReleasesOur team is continually evaluating businesses with commercial products, proven capabilities or where synergies exist with our current product offerings for merger or acquisition opportunitiesBusiness Development